| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate binding | 3.78e-05 | 121 | 151 | 7 | GO:1902936 | |
| GeneOntologyMolecularFunction | selenide, water dikinase activity | 5.68e-05 | 2 | 151 | 2 | GO:0004756 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, paired acceptors | 5.68e-05 | 2 | 151 | 2 | GO:0016781 | |
| GeneOntologyMolecularFunction | bone sialoprotein binding | 5.68e-05 | 2 | 151 | 2 | GO:0044730 | |
| GeneOntologyMolecularFunction | recombination hotspot binding | 5.68e-05 | 2 | 151 | 2 | GO:0010844 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate binding | 8.46e-05 | 95 | 151 | 6 | GO:0005546 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | GBF1 GARNL3 KALRN ARHGEF5 CYTH1 ARFGEF2 GRB2 ARFGEF1 TBC1D9 KRIT1 DOCK5 PLCB1 ALDH1A1 | 1.29e-04 | 507 | 151 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | GBF1 GARNL3 KALRN ARHGEF5 CYTH1 ARFGEF2 GRB2 ARFGEF1 TBC1D9 KRIT1 DOCK5 PLCB1 ALDH1A1 | 1.29e-04 | 507 | 151 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 1.39e-04 | 199 | 151 | 8 | GO:1901981 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | TOM1L2 GBF1 ANXA2 ANXA2P2 PHLDA2 KRIT1 COMMD1 AP2A2 PLCB1 DNM2 | 1.50e-04 | 316 | 151 | 10 | GO:0035091 |
| GeneOntologyMolecularFunction | S100 protein binding | 1.80e-04 | 15 | 151 | 3 | GO:0044548 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | GBF1 GARNL3 KALRN ANXA2 COL28A1 ARHGEF5 ANXA2P2 CYTH1 ARFGEF2 GRB2 ARFGEF1 NLRP1 TBC1D9 KRIT1 DOCK5 ACSL1 PPP2R1B FRY TAOK3 DBF4 PLCB1 ALDH1A1 SERPINA9 | 4.15e-04 | 1418 | 151 | 23 | GO:0030234 |
| GeneOntologyMolecularFunction | phospholipase A2 inhibitor activity | 5.60e-04 | 5 | 151 | 2 | GO:0019834 | |
| GeneOntologyMolecularFunction | pheromone binding | 5.60e-04 | 5 | 151 | 2 | GO:0005550 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TUT4 KALRN STK17B MATK POLG FN3KRP NME2P1 CDC42BPB POLR3A SEPHS2 SEPHS1 TAOK3 DBF4 CDK11B PEAK1 TSSK3 UAP1L1 | 7.50e-04 | 938 | 151 | 17 | GO:0016772 |
| GeneOntologyMolecularFunction | uridylyltransferase activity | 1.16e-03 | 7 | 151 | 2 | GO:0070569 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | CETN1 CETN2 ARHGEF5 DDB1 DICER1 BICD1 DOCK5 ALMS1 PLEC TNNT1 CNOT1 TRIM37 EP300 DYNC1H1 | 1.01e-05 | 475 | 150 | 14 | GO:0140694 |
| GeneOntologyBiologicalProcess | regulation of ARF protein signal transduction | 2.14e-05 | 23 | 150 | 4 | GO:0032012 | |
| GeneOntologyBiologicalProcess | ARF protein signal transduction | 2.55e-05 | 24 | 150 | 4 | GO:0032011 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 3.55e-05 | 26 | 150 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle receptor binding | 5.25e-05 | 2 | 150 | 2 | GO:1905597 | |
| GeneOntologyBiologicalProcess | selenocysteine biosynthetic process | 5.25e-05 | 2 | 150 | 2 | GO:0016260 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | TOM1L2 ANK1 ANXA2 ARHGEF5 GRB2 ARFGEF1 GRIK5 PRDM7 BICD1 PRDM9 STXBP1 ALMS1 MKI67 PLCB1 SMARCA4 CDK11B EIF4G3 YME1L1 CNOT1 TRIM37 EP300 DYNC1H1 DNM2 | 1.06e-04 | 1342 | 150 | 23 | GO:0033043 |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 1.47e-04 | 37 | 150 | 4 | GO:0051446 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor-mediated endocytosis involved in cholesterol transport | 1.57e-04 | 3 | 150 | 2 | GO:1905602 | |
| GeneOntologyBiologicalProcess | positive regulation of long-chain fatty acid import across plasma membrane | 1.57e-04 | 3 | 150 | 2 | GO:0010747 | |
| GeneOntologyBiologicalProcess | negative regulation of low-density lipoprotein particle receptor catabolic process | 1.57e-04 | 3 | 150 | 2 | GO:0032804 | |
| GeneOntologyBiologicalProcess | organelle assembly | GBF1 CCDC146 CETN1 CETN2 ARHGEF5 DDB1 DICER1 BICD1 DOCK5 AKAP4 ALMS1 PLEC DNAAF1 TNNT1 CNOT1 TRIM37 EP300 DYNC1H1 CFAP46 DNM2 | 2.25e-04 | 1138 | 150 | 20 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 2.69e-04 | 172 | 150 | 7 | GO:0051783 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | GPRASP1 ACADM ACADSB ABHD12B OBP2A ANXA2 ANXA2P2 ACOX1 VPS33A DUOX2 CPT1B KYAT1 PRDX6 EEF1A1 ACSL1 PAFAH1B2 EIF4G1 PLCB1 EIF4G3 EP300 DNM2 | 2.95e-04 | 1253 | 150 | 21 | GO:0044248 |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle clearance | 3.12e-04 | 4 | 150 | 2 | GO:1905581 | |
| GeneOntologyBiologicalProcess | positive regulation of reciprocal meiotic recombination | 3.12e-04 | 4 | 150 | 2 | GO:0010845 | |
| GeneOntologyBiologicalProcess | regulation of reciprocal meiotic recombination | 3.12e-04 | 4 | 150 | 2 | GO:0010520 | |
| GeneOntologyBiologicalProcess | negative regulation of receptor catabolic process | 3.12e-04 | 4 | 150 | 2 | GO:2000645 | |
| GeneOntologyBiologicalProcess | selenocysteine metabolic process | 3.12e-04 | 4 | 150 | 2 | GO:0016259 | |
| GeneOntologyBiologicalProcess | positive regulation of long-chain fatty acid import into cell | 3.12e-04 | 4 | 150 | 2 | GO:0140214 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular cholesterol transport | 3.12e-04 | 4 | 150 | 2 | GO:0032385 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular sterol transport | 3.12e-04 | 4 | 150 | 2 | GO:0032382 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 3.18e-04 | 45 | 150 | 4 | GO:0040020 | |
| GeneOntologyBiologicalProcess | centriole replication | 3.76e-04 | 47 | 150 | 4 | GO:0007099 | |
| GeneOntologyBiologicalProcess | protein deacetylation | 3.76e-04 | 47 | 150 | 4 | GO:0006476 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane organization | 3.92e-04 | 20 | 150 | 3 | GO:1903729 | |
| GeneOntologyCellularComponent | axon | SLC4A8 ANK1 ACADM POLG COPG2 GRIK5 GPRIN1 DDC DICER1 SLC1A7 SLC8A3 STXBP1 LRP2 ALDH1A1 PLEC NEXN DYNC1H1 DNM2 | 6.10e-05 | 891 | 148 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | AnxA2-p11 complex | 1.49e-04 | 3 | 148 | 2 | GO:1990665 | |
| GeneOntologyCellularComponent | PCSK9-AnxA2 complex | 1.49e-04 | 3 | 148 | 2 | GO:1990667 | |
| GeneOntologyCellularComponent | actin cytoskeleton | KALRN ANXA2 STK17B ARHGEF5 ANXA2P2 CDC42BPB EEF1A1 SMTN DOCK5 PEAK1 TNNT1 NEXN DNM2 | 2.36e-04 | 576 | 148 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | myelin sheath | 9.16e-04 | 217 | 148 | 7 | GO:0043209 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | KALRN ANXA2 ANXA2P2 VPS33A ARFGEF2 ARFGEF1 DICER1 PRDX6 BICD1 SLC8A3 AKAP4 STXBP1 PLSCR2 PLEC TRIM37 DNM2 | 9.72e-04 | 934 | 148 | 16 | GO:0048471 |
| GeneOntologyCellularComponent | myelin sheath adaxonal region | 1.02e-03 | 7 | 148 | 2 | GO:0035749 | |
| GeneOntologyCellularComponent | peroxisome | 1.05e-03 | 162 | 148 | 6 | GO:0005777 | |
| GeneOntologyCellularComponent | microbody | 1.05e-03 | 162 | 148 | 6 | GO:0042579 | |
| GeneOntologyCellularComponent | distal axon | SLC4A8 POLG COPG2 GRIK5 GPRIN1 DICER1 SLC1A7 SLC8A3 LRP2 DNM2 | 1.09e-03 | 435 | 148 | 10 | GO:0150034 |
| GeneOntologyCellularComponent | centriole | 1.43e-03 | 172 | 148 | 6 | GO:0005814 | |
| GeneOntologyCellularComponent | microbody membrane | 1.46e-03 | 69 | 148 | 4 | GO:0031903 | |
| GeneOntologyCellularComponent | peroxisomal membrane | 1.46e-03 | 69 | 148 | 4 | GO:0005778 | |
| MousePheno | microphthalmia | SOX1 NDST1 SLC4A8 NLRP1 SMOC1 FREM1 RBM22 MTF1 TKT LRP2 PLCB1 EP300 AFF4 DNM2 | 2.16e-06 | 362 | 118 | 14 | MP:0001297 |
| MousePheno | abnormal eye size | SOX1 NDST1 SLC4A8 NLRP1 SMOC1 FREM1 RBM22 MTF1 TKT LRP2 PLCB1 EP300 AFF4 DNM2 | 3.26e-06 | 375 | 118 | 14 | MP:0002697 |
| Domain | Sec7_N | 1.86e-06 | 4 | 146 | 3 | IPR032691 | |
| Domain | Sec7_N | 1.86e-06 | 4 | 146 | 3 | PF12783 | |
| Domain | - | 4.57e-06 | 15 | 146 | 4 | 1.10.1000.11 | |
| Domain | Sec7 | 4.57e-06 | 15 | 146 | 4 | PF01369 | |
| Domain | Sec7_alpha_orthog | 4.57e-06 | 15 | 146 | 4 | IPR023394 | |
| Domain | SEC7 | 6.06e-06 | 16 | 146 | 4 | PS50190 | |
| Domain | Sec7 | 6.06e-06 | 16 | 146 | 4 | SM00222 | |
| Domain | Sec7_dom | 6.06e-06 | 16 | 146 | 4 | IPR000904 | |
| Domain | ARM-type_fold | GPRASP1 DNAJC13 GBF1 ARFGEF2 ARFGEF1 COPG2 DOCK5 PPP2R1B AP2A2 XPO6 EIF4G1 EIF4G3 | 1.47e-05 | 339 | 146 | 12 | IPR016024 |
| Domain | SPS/SelD | 6.07e-05 | 2 | 146 | 2 | IPR004536 | |
| Domain | - | 1.26e-04 | 13 | 146 | 3 | 1.10.540.10 | |
| Domain | AcylCoA_DH/ox_N | 1.26e-04 | 13 | 146 | 3 | IPR013786 | |
| Domain | - | 1.81e-04 | 3 | 146 | 2 | 3.90.650.10 | |
| Domain | von_Ebner_gland | 1.81e-04 | 3 | 146 | 2 | IPR002450 | |
| Domain | Acyl-CoA_Oxase/DH_cen-dom | 1.99e-04 | 15 | 146 | 3 | IPR006091 | |
| Domain | AcylCoA_DH/oxidase_NM_dom | 1.99e-04 | 15 | 146 | 3 | IPR009100 | |
| Domain | Acyl-CoA_dh_M | 1.99e-04 | 15 | 146 | 3 | PF02770 | |
| Domain | AcylCo_DH/oxidase_C | 2.43e-04 | 16 | 146 | 3 | IPR009075 | |
| Domain | DCB_dom | 3.60e-04 | 4 | 146 | 2 | IPR032629 | |
| Domain | - | 3.60e-04 | 4 | 146 | 2 | 3.30.1330.10 | |
| Domain | Clathrin_a/coatomer_app_sub_C | 3.60e-04 | 4 | 146 | 2 | IPR015873 | |
| Domain | Sec7_C | 3.60e-04 | 4 | 146 | 2 | IPR015403 | |
| Domain | DUF1981 | 3.60e-04 | 4 | 146 | 2 | PF09324 | |
| Domain | AIRS_C | 3.60e-04 | 4 | 146 | 2 | PF02769 | |
| Domain | AIRS | 3.60e-04 | 4 | 146 | 2 | PF00586 | |
| Domain | PurM-like_N | 3.60e-04 | 4 | 146 | 2 | IPR016188 | |
| Domain | AIR_synth_C_dom | 3.60e-04 | 4 | 146 | 2 | IPR010918 | |
| Domain | DCB | 3.60e-04 | 4 | 146 | 2 | PF16213 | |
| Domain | - | 3.60e-04 | 4 | 146 | 2 | 3.30.310.30 | |
| Domain | - | 3.63e-04 | 222 | 146 | 8 | 1.25.10.10 | |
| Domain | Transketolase_C | 5.98e-04 | 5 | 146 | 2 | IPR033248 | |
| Domain | Transketolase_fam | 5.98e-04 | 5 | 146 | 2 | IPR033247 | |
| Domain | Transketo_C/PFOR_II | 5.98e-04 | 5 | 146 | 2 | IPR009014 | |
| Domain | Transketolase_C | 5.98e-04 | 5 | 146 | 2 | PF02780 | |
| Domain | - | 5.98e-04 | 5 | 146 | 2 | 3.40.50.920 | |
| Domain | MA3 | 8.92e-04 | 6 | 146 | 2 | SM00544 | |
| Domain | MA3 | 8.92e-04 | 6 | 146 | 2 | PF02847 | |
| Domain | Initiation_fac_eIF4g_MI | 8.92e-04 | 6 | 146 | 2 | IPR003891 | |
| Domain | MI | 8.92e-04 | 6 | 146 | 2 | PS51366 | |
| Domain | eIF5C | 1.24e-03 | 7 | 146 | 2 | SM00515 | |
| Domain | W2 | 1.24e-03 | 7 | 146 | 2 | PF02020 | |
| Domain | W2 | 1.24e-03 | 7 | 146 | 2 | PS51363 | |
| Domain | W2_domain | 1.24e-03 | 7 | 146 | 2 | IPR003307 | |
| Domain | ARM-like | 1.30e-03 | 270 | 146 | 8 | IPR011989 | |
| Domain | Sec1-like | 1.65e-03 | 8 | 146 | 2 | IPR001619 | |
| Domain | DHC_N1 | 1.65e-03 | 8 | 146 | 2 | PF08385 | |
| Domain | Transketolase-like_Pyr-bd | 1.65e-03 | 8 | 146 | 2 | IPR005475 | |
| Domain | Sec-1-like_dom2 | 1.65e-03 | 8 | 146 | 2 | IPR027482 | |
| Domain | Sec1 | 1.65e-03 | 8 | 146 | 2 | PF00995 | |
| Domain | Coatomer/calthrin_app_sub_C | 1.65e-03 | 8 | 146 | 2 | IPR009028 | |
| Domain | SSXRD | 1.65e-03 | 8 | 146 | 2 | PF09514 | |
| Domain | SSXRD_motif | 1.65e-03 | 8 | 146 | 2 | IPR019041 | |
| Domain | Transket_pyr | 1.65e-03 | 8 | 146 | 2 | SM00861 | |
| Domain | Transket_pyr | 1.65e-03 | 8 | 146 | 2 | PF02779 | |
| Domain | - | 1.65e-03 | 8 | 146 | 2 | 3.40.50.1910 | |
| Domain | Dynein_heavy_dom-1 | 1.65e-03 | 8 | 146 | 2 | IPR013594 | |
| Domain | Calx_beta | 2.11e-03 | 9 | 146 | 2 | IPR003644 | |
| Domain | Acyl-CoA_DH_CS | 2.11e-03 | 9 | 146 | 2 | IPR006089 | |
| Domain | Calx-beta | 2.11e-03 | 9 | 146 | 2 | PF03160 | |
| Domain | MIF4G | 2.62e-03 | 10 | 146 | 2 | SM00543 | |
| Domain | MIF4G | 2.62e-03 | 10 | 146 | 2 | PF02854 | |
| Domain | ACYL_COA_DH_1 | 2.62e-03 | 10 | 146 | 2 | PS00072 | |
| Domain | ACYL_COA_DH_2 | 2.62e-03 | 10 | 146 | 2 | PS00073 | |
| Domain | MIF4G-like_typ-3 | 2.62e-03 | 10 | 146 | 2 | IPR003890 | |
| Domain | KRAB_RELATED | 3.19e-03 | 11 | 146 | 2 | PS50806 | |
| Domain | Acyl-CoA_dh_N | 3.19e-03 | 11 | 146 | 2 | PF02771 | |
| Domain | Coatomer/clathrin_app_Ig-like | 3.80e-03 | 12 | 146 | 2 | IPR013041 | |
| Domain | ZU5 | 3.80e-03 | 12 | 146 | 2 | PF00791 | |
| Domain | ZU5_dom | 3.80e-03 | 12 | 146 | 2 | IPR000906 | |
| Domain | ANX | 4.47e-03 | 13 | 146 | 2 | SM00335 | |
| Domain | Acyl-CoA_dh_1 | 4.47e-03 | 13 | 146 | 2 | PF00441 | |
| Domain | Annexin_repeat_CS | 4.47e-03 | 13 | 146 | 2 | IPR018252 | |
| Domain | Annexin | 4.47e-03 | 13 | 146 | 2 | PF00191 | |
| Domain | Annexin_repeat | 4.47e-03 | 13 | 146 | 2 | IPR018502 | |
| Domain | Krueppel-associated_box-rel | 4.47e-03 | 13 | 146 | 2 | IPR003655 | |
| Domain | ANNEXIN | 4.47e-03 | 13 | 146 | 2 | PS00223 | |
| Domain | THDP-binding | 4.47e-03 | 13 | 146 | 2 | IPR029061 | |
| Domain | - | 4.47e-03 | 13 | 146 | 2 | 3.40.50.970 | |
| Domain | - | 4.47e-03 | 13 | 146 | 2 | 1.10.220.10 | |
| Domain | Annexin | 5.19e-03 | 14 | 146 | 2 | IPR001464 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.19e-03 | 14 | 146 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.19e-03 | 14 | 146 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.19e-03 | 14 | 146 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.19e-03 | 14 | 146 | 2 | PF08393 | |
| Domain | TIL_dom | 5.19e-03 | 14 | 146 | 2 | IPR002919 | |
| Domain | ATPase_dyneun-rel_AAA | 5.19e-03 | 14 | 146 | 2 | IPR011704 | |
| Domain | MT | 5.19e-03 | 14 | 146 | 2 | PF12777 | |
| Domain | AAA_8 | 5.19e-03 | 14 | 146 | 2 | PF12780 | |
| Domain | CNH | 5.19e-03 | 14 | 146 | 2 | SM00036 | |
| Domain | AAA_5 | 5.19e-03 | 14 | 146 | 2 | PF07728 | |
| Domain | DHC_fam | 5.96e-03 | 15 | 146 | 2 | IPR026983 | |
| Domain | Clathrin/coatomer_adapt-like_N | 5.96e-03 | 15 | 146 | 2 | IPR002553 | |
| Domain | - | 5.96e-03 | 15 | 146 | 2 | 1.25.40.180 | |
| Domain | Dynein_heavy | 5.96e-03 | 15 | 146 | 2 | PF03028 | |
| Domain | Adaptin_N | 5.96e-03 | 15 | 146 | 2 | PF01602 | |
| Domain | CNH | 5.96e-03 | 15 | 146 | 2 | PF00780 | |
| Domain | MIF4-like | 5.96e-03 | 15 | 146 | 2 | IPR016021 | |
| Domain | Dynein_heavy_dom | 5.96e-03 | 15 | 146 | 2 | IPR004273 | |
| Domain | CNH | 5.96e-03 | 15 | 146 | 2 | PS50219 | |
| Domain | CNH_dom | 5.96e-03 | 15 | 146 | 2 | IPR001180 | |
| Pathway | KEGG_FATTY_ACID_METABOLISM | 9.13e-07 | 42 | 112 | 6 | M699 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 8.30e-06 | 17 | 112 | 4 | M2482 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_ACYL_COA_SYNTHESIS | 7.69e-05 | 11 | 112 | 3 | M47626 | |
| Pubmed | GPRASP1 NDST1 VWF KALRN PDHB CYTH1 POLG ARFGEF2 QRICH1 CDC42BPB KRIT1 EEF1A1 BICD1 RBM22 FRY STXBP1 COMMD1 EIF4G1 LRP2 SMARCA4 LRPAP1 PLEC EIF4G3 YME1L1 UAP1L1 TRIM37 EP300 DYNC1H1 AFF4 DNM2 | 4.18e-14 | 1285 | 151 | 30 | 35914814 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | GBF1 ACADM ACADSB PDHB ANXA2 ANXA2P2 U2SURP FN3KRP VPS33A SRM GRB2 DDB1 PRDX6 POLR3A EEF1A1 EEF1A1P5 ACSL1 PPP2R1B IARS2 DNAJC10 EIF4G1 SMARCA4 OGA YME1L1 FUBP3 CNOT1 DYNC1H1 DNM2 | 1.03e-12 | 1257 | 151 | 28 | 37317656 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATP8B4 GBF1 DNAH10 PDHB ANXA2 U2SURP FN3KRP DUOX2 GLOD4 PRDM7 DDB1 DICER1 PRDX6 DARS2 POLR3A EEF1A1 RBM22 IARS2 TM9SF2 AP2A2 TKT EIF4G1 MKI67 SMARCA4 PEAK1 FUBP3 CNOT1 DYNC1H1 | 1.97e-11 | 1425 | 151 | 28 | 30948266 |
| Pubmed | TOM1L2 ACSL6 DNAJC13 VWF KALRN PDHB ANXA2 ANXA2P2 ARFGEF2 GRB2 DDB1 CDC42BPB PRDX6 EEF1A1 CEP170 USP5 STXBP1 AP2A2 TKT PAFAH1B2 EIF4G1 SMARCA4 PEAK1 PLEC EIF4G3 CNOT1 DYNC1H1 DNM2 | 2.17e-11 | 1431 | 151 | 28 | 37142655 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | DNAJC13 TUT4 GBF1 CETN2 SRP54 LARP4 CDC42BPB DICER1 PRDX6 NECAP1 CEP170 RBM22 SCML2 TKT EIF4G1 MKI67 PLEC EIF4G3 FUBP3 CNOT1 | 5.90e-11 | 724 | 151 | 20 | 36232890 |
| Pubmed | U2SURP ANXA11 COPG2 LARP4 DDB1 DICER1 CEP170 USP5 IARS2 PREP EIF4G1 MKI67 SMARCA4 PLEC EIF4G3 FUBP3 CNOT1 DYNC1H1 DNM2 | 7.71e-11 | 653 | 151 | 19 | 22586326 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | DNAJC13 GBF1 MATK ARFGEF2 GPRIN1 TBC1D9 SMTN NCOR2 SCML2 XPO6 DBF4 TKT EIF4G1 MKI67 SMARCA4 KDM2B CDK11B PLEC OGA DNM2 | 1.90e-10 | 774 | 151 | 20 | 15302935 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DNAJC13 U2SURP ANXA11 VPS33A ARFGEF2 SRP54 COPG2 DDB1 DOCK5 NCOR2 PPP2R1B XPO6 SMARCA4 PLEC CNOT1 DYNC1H1 DNM2 | 7.71e-10 | 582 | 151 | 17 | 20467437 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TOM1L2 GBF1 PDHB CETN2 ANXA2 U2SURP COPG2 DDB1 PRDX6 EEF1A1 CEP170 USP5 SEPHS1 AP2A2 PREP TKT EIF4G1 PLEC EIF4G3 OGA CNOT1 DYNC1H1 DNM2 | 1.08e-09 | 1149 | 151 | 23 | 35446349 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | DNAJC13 GBF1 ANXA2 ARFGEF2 CDC42BPB DICER1 EEF1A1 DOCK5 EIF4G1 PLEC CNOT1 | 1.53e-09 | 202 | 151 | 11 | 33005030 |
| Pubmed | GBF1 ACADSB CETN2 ANXA2 SRP54 SMOC1 LARP4 DDB1 CDC42BPB DICER1 PRDX6 EEF1A1 CEP170 AP2A2 TKT EIF4G1 MKI67 SMARCA4 CDK11B PLEC FUBP3 CNOT1 DYNC1H1 AFF4 | 6.19e-09 | 1371 | 151 | 24 | 36244648 | |
| Pubmed | VWF CDC42BPB DARS2 EEF1A1 CEP170 ACSL1 USP5 TKT PAFAH1B2 EIF4G1 PLEC DYNC1H1 DNM2 | 7.00e-09 | 360 | 151 | 13 | 33111431 | |
| Pubmed | DNAJC13 GBF1 ANXA2 ACOX1 ANXA11 ARFGEF2 LARP4 PRDX6 POLR3A EEF1A1 ACSL1 NCOR2 DNAJC10 PREP EIF4G1 MKI67 SMARCA4 OGA YME1L1 FUBP3 CNOT1 DYNC1H1 | 7.75e-09 | 1168 | 151 | 22 | 19946888 | |
| Pubmed | GPRASP1 DNAJC13 SLC4A8 KALRN CYTH1 GRIK5 DDB1 CDC42BPB EEF1A1 CEP170 NCOR2 FRY AP2A2 EIF4G1 PLCB1 SMARCA4 CNOT1 DYNC1H1 AFF4 DNM2 | 7.92e-09 | 963 | 151 | 20 | 28671696 | |
| Pubmed | 1.18e-08 | 7 | 151 | 4 | 17197235 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ANXA2 VPS33A SRM COPG2 DDB1 PRDX6 EEF1A1 USP5 IARS2 AP2A2 TKT EIF4G1 ALDH1A1 PEAK1 PLEC CNOT1 DYNC1H1 DNM2 | 1.60e-08 | 807 | 151 | 18 | 30575818 |
| Pubmed | PDHB ANXA2 U2SURP FN3KRP GRB2 SRP54 LARP4 CDC42BPB EEF1A1 CEP170 INTS10 IARS2 DNAJC10 AP2A2 EIF4G1 PLEC CNOT1 DYNC1H1 | 1.66e-08 | 809 | 151 | 18 | 32129710 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | TOM1L2 DNAJC13 TUT4 VWF KALRN ANXA2 ANXA11 GRB2 DDB1 CDC42BPB DDC PRDX6 EEF1A1 STXBP1 TKT PAFAH1B2 LRP2 ALDH1A1 DYNC1H1 DNM2 | 1.92e-08 | 1016 | 151 | 20 | 19056867 |
| Pubmed | DNAJC13 GBF1 ACADM PDHB COPG2 DDB1 PRDX6 USP5 DNAJC10 EIF4G1 SMARCA4 PLEC FUBP3 CNOT1 DYNC1H1 DNM2 | 2.13e-08 | 638 | 151 | 16 | 33239621 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DNAJC13 PDHB U2SURP SRM SRP54 LARP4 DDB1 POLR3A SMTN ACSL1 NCOR2 USP5 RBM22 AP2A2 TKT EIF4G1 MKI67 SMARCA4 PLEC NEXN YME1L1 FUBP3 DYNC1H1 | 2.28e-08 | 1353 | 151 | 23 | 29467282 |
| Pubmed | ANXA2 GRB2 DDB1 NECAP1 EEF1A1 EEF1A1P5 AP2A2 PEAK1 CNOT1 DYNC1H1 DNM2 | 2.66e-08 | 266 | 151 | 11 | 19380743 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DNAJC13 GBF1 PDHB ANXA2 ANXA11 ARFGEF1 SRP54 GLOD4 GPRIN1 DDB1 PRDX6 EEF1A1 CEP170 NCOR2 USP5 PPP2R1B SEPHS1 IARS2 PAFAH1B2 EIF4G1 NEXN FUBP3 CNOT1 | 2.75e-08 | 1367 | 151 | 23 | 32687490 |
| Pubmed | SOX1 ANXA2 ARHGEF5 ANXA2P2 U2SURP VPS33A EEF1A1 MKI67 PLEC CNOT1 DYNC1H1 | 5.19e-08 | 284 | 151 | 11 | 29459677 | |
| Pubmed | MACC1 PDHB CETN2 ANXA2 U2SURP DUOX2 FER1L6 EEF1A1 SEPHS2 RBM22 SEPHS1 STXBP1 DNAJC10 AP2A2 TKT EIF4G1 ALDH1A1 PLEC ATP1A4 EIF4G3 TNNT1 FUBP3 CFAP46 | 7.22e-08 | 1442 | 151 | 23 | 35575683 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 32943107 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 23386609 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 18003980 | ||
| Pubmed | PDHB ANXA2 VPS33A GRB2 NME2P1 SRP54 LARP4 DDB1 DICER1 PRDX6 DARS2 POLR3A NECAP1 EEF1A1 PPP2R1B RBM22 DNAJC10 AP2A2 TKT EIF4G1 YME1L1 FUBP3 | 8.18e-08 | 1335 | 151 | 22 | 29229926 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | GPRASP1 ACADM ACADSB CETN1 CETN2 ANXA2P2 FN3KRP SRM GRB2 DICER1 POLR3A USP5 PPP2R1B SCML2 EIF4G1 PLEC EIF4G3 OGA CNOT1 | 8.42e-08 | 1005 | 151 | 19 | 19615732 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | PDHB STK17B FN3KRP GRB2 DICER1 PRDX6 DARS2 CEP170 NCOR2 TAOK3 AP2A2 RASSF6 EIF4G1 CDK11B PLEC EP300 AFF4 DNM2 | 9.72e-08 | 910 | 151 | 18 | 36736316 |
| Pubmed | GPRASP1 TUT4 SLC4A8 ACADM KALRN PDHB ANXA2 ANXA2P2 U2SURP VPS33A GPRIN1 CDC42BPB CEP170 STXBP1 AP2A2 PLCB1 PEAK1 PLEC EIF4G3 CNOT1 | 1.23e-07 | 1139 | 151 | 20 | 36417873 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | U2SURP SRP54 COPG2 GLOD4 GPRIN1 DDB1 PRDX6 CEP170 IARS2 SCML2 ALMS1 TKT MKI67 SMARCA4 EIF4G3 OGA AFF4 DNM2 | 1.43e-07 | 934 | 151 | 18 | 33916271 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ANK1 OR5B2 COL28A1 GRIK5 CPT1B GPRIN1 DARS2 EEF1A1 TMCO4 DOCK5 FRY LRP2 FUBP3 CNOT1 SERPINA9 DYNC1H1 | 1.49e-07 | 736 | 151 | 16 | 29676528 |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | ACADSB PDHB ANXA2 COPG2 LARP4 DDB1 EEF1A1 PPP2R1B IARS2 DNAJC10 TKT YME1L1 DYNC1H1 DNM2 | 1.96e-07 | 565 | 151 | 14 | 33567341 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | PDHB U2SURP COPG2 PRDX6 EEF1A1 ACSL1 RBM22 COMMD1 ALMS1 PREP DBF4 MKI67 EIF4G3 OGA DYNC1H1 | 2.58e-07 | 670 | 151 | 15 | 22990118 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DNAJC13 KALRN PDHB ANXA2 CYTH1 U2SURP SRP54 DDB1 EEF1A1 CEP170 RBM22 DNAJC10 EIF4G1 SMARCA4 CDK11B PLEC CNOT1 DYNC1H1 AFF4 | 2.61e-07 | 1082 | 151 | 19 | 38697112 |
| Pubmed | MAGEB2 FN3KRP ARFGEF2 ARFGEF1 DDB1 DNAJC10 ALMS1 TKT EIF4G1 MKI67 SMARCA4 PLEC CNOT1 | 2.77e-07 | 494 | 151 | 13 | 26831064 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | DNAJC13 TUT4 ANXA2 ANXA2P2 NCOR2 SMARCA4 FUBP3 CNOT1 DYNC1H1 | 2.84e-07 | 203 | 151 | 9 | 22083510 |
| Pubmed | DNAJC13 PDHB ACOX1 U2SURP SRM DDB1 RBM22 TAOK3 MKI67 PLEC DYNC1H1 | 3.15e-07 | 340 | 151 | 11 | 29478914 | |
| Pubmed | TOM1L2 VWF ARFGEF2 QRICH1 DDB1 EEF1A1 NCOR2 USP5 TM9SF2 AP2A2 EIF4G1 PLEC DYNC1H1 DNM2 | 3.37e-07 | 591 | 151 | 14 | 15231748 | |
| Pubmed | U2SURP SRM GRB2 SRP54 QRICH1 EEF1A1 CEP170 ACSL1 NCOR2 RBM22 TAOK3 TKT MKI67 SMARCA4 FUBP3 CNOT1 EP300 DYNC1H1 DNM2 | 3.49e-07 | 1103 | 151 | 19 | 34189442 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 3.78e-07 | 104 | 151 | 7 | 31240132 | |
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 4.09e-07 | 212 | 151 | 9 | 33462405 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | ACADM PDHB U2SURP ANXA11 SRP54 DARS2 IARS2 DNAJC10 AP2A2 TKT PAFAH1B2 EIF4G1 FUBP3 DNM2 | 4.63e-07 | 607 | 151 | 14 | 39147351 |
| Pubmed | CETN2 ANXA2 SRP54 QRICH1 DDB1 PRDX6 POLR3A EEF1A1 NCOR2 USP5 TKT EIF4G1 MKI67 SMARCA4 CDK11B PLEC FUBP3 EP300 | 4.73e-07 | 1014 | 151 | 18 | 32416067 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | PDHB ANXA11 SRP54 COPG2 GRIK5 DARS2 POLR3A IARS2 STXBP1 SMARCA4 EIF4G3 YME1L1 FUBP3 CNOT1 DYNC1H1 | 4.81e-07 | 704 | 151 | 15 | 29955894 |
| Pubmed | PDHB ANXA2 SRM GRB2 PRDX6 EEF1A1 AP2A2 TKT PAFAH1B2 EIF4G1 PLEC FUBP3 CNOT1 DYNC1H1 DNM2 | 5.08e-07 | 707 | 151 | 15 | 19738201 | |
| Pubmed | ADAMTSL1 PDHB ANXA11 FN3KRP DDC DICER1 CEP170 IARS2 PEAK1 UAP1L1 | 5.82e-07 | 288 | 151 | 10 | 38496616 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | ACSL6 ANK1 PDHB GRIK5 PRDX6 EEF1A1 ACSL1 USP5 STXBP1 AP2A2 ALDH1A1 ATP1A4 DYNC1H1 DNM2 | 6.07e-07 | 621 | 151 | 14 | 22794259 |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | GPRASP1 U2SURP SRP54 LARP4 DDB1 DICER1 DARS2 CEP170 ALMS1 MKI67 CNOT1 | 6.18e-07 | 364 | 151 | 11 | 24778252 |
| Pubmed | TUT4 DNAH10 GRB2 CDC42BPB POLR3A SEPHS2 SEPHS1 AP2A2 LRP2 PLCB1 SMARCA4 CDK11B UAP1L1 EP300 DNM2 | 7.57e-07 | 730 | 151 | 15 | 34857952 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ANXA2 U2SURP FN3KRP GRB2 GLOD4 LARP4 DDB1 PRDX6 DARS2 EEF1A1 EEF1A1P5 CEP170 USP5 RBM22 DNAJC10 AP2A2 TKT EIF4G1 SMARCA4 PLEC DYNC1H1 | 9.10e-07 | 1415 | 151 | 21 | 28515276 |
| Pubmed | ANXA2 ANXA2P2 ACOX1 FN3KRP GRB2 COPG2 EEF1A1 EEF1A1P5 DNAJC10 AP2A2 TKT EIF4G1 MKI67 PLEC FUBP3 DYNC1H1 | 9.15e-07 | 844 | 151 | 16 | 25963833 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ANXA2 ANXA2P2 U2SURP ANXA11 NME2P1 COPG2 EEF1A1 EEF1A1P5 CEP170 NCOR2 SCML2 EIF4G1 MKI67 SMARCA4 CDK11B FUBP3 AFF4 | 9.56e-07 | 954 | 151 | 17 | 36373674 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ANXA2 U2SURP ANXA11 VPS33A NME2P1 POLR3A EEF1A1 USP5 SEPHS2 SEPHS1 EIF4G1 SMARCA4 PLEC EIF4G3 DYNC1H1 DNM2 | 9.58e-07 | 847 | 151 | 16 | 35235311 |
| Pubmed | ACADM ACADSB PDHB COPG2 DDB1 CEP170 ACSL1 INTS10 AP2A2 EIF4G1 CNOT1 DYNC1H1 DNM2 | 1.13e-06 | 560 | 151 | 13 | 35241646 | |
| Pubmed | ANXA2P2 LARP4 DDB1 PRDX6 NECAP1 SMTN CEP170 RBM22 SCML2 PREP NEXN FUBP3 | 1.16e-06 | 472 | 151 | 12 | 38943005 | |
| Pubmed | ACADM ACADSB GRB2 COPG2 DDB1 DICER1 POLR3A SMTN CEP170 USP5 PPP2R1B IARS2 COMMD1 DNAJC10 AP2A2 EIF4G1 MKI67 NEXN FUBP3 CNOT1 DYNC1H1 | 1.20e-06 | 1440 | 151 | 21 | 30833792 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ANK1 ACADM PDHB U2SURP COPG2 PRDX6 DARS2 EEF1A1 RBM22 TAOK3 AP2A2 TKT EIF4G1 MKI67 SMARCA4 CDK11B PLEC FUBP3 DYNC1H1 DNM2 | 1.21e-06 | 1318 | 151 | 20 | 30463901 |
| Pubmed | A crucial role for Arf6 in the response of commissural axons to Slit. | 1.26e-06 | 19 | 151 | 4 | 30674481 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | ANXA2P2 U2SURP NME2P1 PRDX6 EEF1A1 EEF1A1P5 IARS2 TKT PLEC NEXN FUBP3 DYNC1H1 | 1.29e-06 | 477 | 151 | 12 | 31300519 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | PDHB U2SURP COPG2 LARP4 PRDX6 NCOR2 STXBP1 AP2A2 EIF4G1 SMARCA4 CDK11B EIF4G3 CNOT1 DYNC1H1 | 1.36e-06 | 665 | 151 | 14 | 30457570 |
| Pubmed | 1.47e-06 | 183 | 151 | 8 | 23956138 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MAGEB2 PDHB CETN2 ANXA2 U2SURP DDB1 PRDX6 DARS2 EEF1A1P5 NCOR2 RBM22 TKT MKI67 SMARCA4 CDK11B PLEC AFF4 | 1.56e-06 | 989 | 151 | 17 | 36424410 |
| Pubmed | 1.59e-06 | 6 | 151 | 3 | 11018072 | ||
| Pubmed | Quantitative interaction proteomics of neurodegenerative disease proteins. | MAGEB2 CETN2 ANXA11 DDB1 EEF1A1 COMMD1 TKT EIF4G1 CDK11B PLEC | 1.64e-06 | 323 | 151 | 10 | 25959826 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | ANXA2 VPS33A GLOD4 GPRIN1 CDC42BPB PRDX6 DARS2 EEF1A1 CEP170 PPP2R1B AP2A2 EIF4G3 | 2.02e-06 | 498 | 151 | 12 | 36634849 |
| Pubmed | 2.03e-06 | 191 | 151 | 8 | 33762435 | ||
| Pubmed | A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. | VWF ACADSB GRB2 SRP54 DARS2 POLR3A KRIT1 TKT NEXN YME1L1 DNM2 | 2.42e-06 | 419 | 151 | 11 | 28700943 |
| Pubmed | DNAJC13 ABHD12B PDHB ANXA2 COPG2 GLOD4 PRDX6 EEF1A1 IARS2 TKT MKI67 SMARCA4 ZNF396 PLEC DYNC1H1 | 2.45e-06 | 803 | 151 | 15 | 36517590 | |
| Pubmed | ANXA2 ARHGEF5 GRB2 GLOD4 DDB1 CEP170 DOCK5 RBM22 AP2A2 SMARCA4 LRPAP1 PEAK1 PLEC YME1L1 FUBP3 DNM2 | 2.63e-06 | 916 | 151 | 16 | 32203420 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 2.87e-06 | 344 | 151 | 10 | 30333137 | |
| Pubmed | 3.22e-06 | 272 | 151 | 9 | 31010829 | ||
| Pubmed | 3.41e-06 | 274 | 151 | 9 | 34244482 | ||
| Pubmed | MAGEB2 ACADSB PDHB ANXA2 DDB1 PRDX6 DARS2 EEF1A1 CEP170 DNAJC10 AP2A2 EIF4G1 DYNC1H1 DNM2 | 3.69e-06 | 725 | 151 | 14 | 27025967 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TOM1L2 OBP2A SRM ARFGEF1 COPG2 QRICH1 DARS2 USP5 TM9SF2 XPO6 EIF4G1 EIF4G3 OGA YME1L1 FUBP3 DYNC1H1 | 3.75e-06 | 942 | 151 | 16 | 31073040 |
| Pubmed | DNAJC13 ANXA2 U2SURP VPS33A SRM GRB2 SRP54 LARP4 CDC42BPB DARS2 CEP170 TM9SF2 DNAJC10 PREP MKI67 LRPAP1 CNOT1 DYNC1H1 DNM2 | 3.80e-06 | 1297 | 151 | 19 | 33545068 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | ANXA2 ANXA2P2 U2SURP LARP4 DDB1 EEF1A1 EEF1A1P5 SMTN AP2A2 TKT MKI67 SMARCA4 CDK11B PLEC NEXN DYNC1H1 | 4.12e-06 | 949 | 151 | 16 | 36574265 |
| Pubmed | SRP54 COPG2 DDB1 DARS2 CEP170 USP5 TKT OGA FUBP3 CNOT1 DYNC1H1 DNM2 | 4.12e-06 | 534 | 151 | 12 | 35032548 | |
| Pubmed | 4.42e-06 | 8 | 151 | 3 | 23267103 | ||
| Pubmed | ACADSB VPS33A FER1L6 NCOR2 RBM22 STXBP1 PLCB1 KDM2B DNAAF1 YME1L1 CNOT1 EP300 DNM2 | 4.68e-06 | 638 | 151 | 13 | 31182584 | |
| Pubmed | 4.88e-06 | 215 | 151 | 8 | 35973513 | ||
| Pubmed | ANXA2 GPRIN1 PRDX6 CEP170 SCML2 ALMS1 SMARCA4 KDM2B PEAK1 CNOT1 EP300 DYNC1H1 | 5.46e-06 | 549 | 151 | 12 | 38280479 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | COPG2 KRIT1 INTS10 EIF4G1 SMARCA4 CDK11B PLEC EIF4G3 DYNC1H1 DNM2 | 5.46e-06 | 370 | 151 | 10 | 22922362 |
| Pubmed | TUT4 ANXA11 EEF1A1 DOCK5 NCOR2 USP5 EIF4G1 MKI67 SMARCA4 KDM2B OGA YME1L1 EP300 DYNC1H1 | 5.76e-06 | 754 | 151 | 14 | 35906200 | |
| Pubmed | 6.20e-06 | 295 | 151 | 9 | 26209609 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MAGEB2 DNAJC13 PDHB ANXA2 LARP4 DDB1 CEP170 DNAJC10 EIF4G1 MKI67 SMARCA4 EIF4G3 YME1L1 CNOT1 | 6.21e-06 | 759 | 151 | 14 | 35915203 |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | TOM1L2 PDHB ANXA2 GRB2 GPRIN1 EEF1A1 CEP170 USP5 SEPHS1 STXBP1 TKT DYNC1H1 | 6.43e-06 | 558 | 151 | 12 | 35063084 |
| Pubmed | 6.80e-06 | 225 | 151 | 8 | 12168954 | ||
| Pubmed | Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. | 7.05e-06 | 161 | 151 | 7 | 32572027 | |
| Pubmed | ACADM PDHB FN3KRP COPG2 QRICH1 PRDX6 EEF1A1 EEF1A1P5 USP5 IARS2 AP2A2 PREP TKT EIF4G1 DYNC1H1 | 7.15e-06 | 878 | 151 | 15 | 37223481 | |
| Pubmed | 7.45e-06 | 29 | 151 | 4 | 36800290 | ||
| Pubmed | ACADSB PDHB ANXA2 U2SURP GRB2 COPG2 DDB1 PRDX6 EEF1A1 NCOR2 RBM22 AP2A2 EIF4G1 MKI67 KDM2B DYNC1H1 AFF4 DNM2 | 8.53e-06 | 1247 | 151 | 18 | 27684187 | |
| Pubmed | 8.96e-06 | 167 | 151 | 7 | 22159717 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 9.34e-06 | 235 | 151 | 8 | 28378594 | |
| Pubmed | 9.71e-06 | 312 | 151 | 9 | 37120454 | ||
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 1.04e-05 | 113 | 151 | 6 | 34474245 | |
| Pubmed | 1.05e-05 | 399 | 151 | 10 | 35987950 | ||
| Pubmed | ANXA2 SRM GRB2 PRDX6 EEF1A1 EEF1A1P5 EIF4G1 PLEC FUBP3 DYNC1H1 DNM2 | 1.08e-05 | 491 | 151 | 11 | 22623428 | |
| Pubmed | TUT4 ARFGEF2 ARFGEF1 COPG2 PRDX6 EEF1A1 PPP2R1B AP2A2 EIF4G1 EIF4G3 | 1.36e-05 | 411 | 151 | 10 | 36652389 | |
| Interaction | LRRC31 interactions | DNAJC13 GBF1 ANXA2 ARFGEF2 CDC42BPB DICER1 EEF1A1 DOCK5 EIF4G1 PLEC CNOT1 | 4.28e-07 | 205 | 151 | 11 | int:LRRC31 |
| Interaction | C9orf72 interactions | GBF1 ACADM ACADSB PDHB ANXA2 ANXA2P2 U2SURP FN3KRP VPS33A SRM GRB2 DDB1 PRDX6 POLR3A EEF1A1 EEF1A1P5 ACSL1 PPP2R1B IARS2 DNAJC10 EIF4G1 SMARCA4 OGA YME1L1 FUBP3 CNOT1 DYNC1H1 DNM2 | 4.90e-07 | 1319 | 151 | 28 | int:C9orf72 |
| Interaction | H2AX interactions | MAGEB2 CETN1 CETN2 ANXA2 ANXA2P2 GRB2 DUOX2 DDB1 PRDX6 EEF1A1 EEF1A1P5 SCML2 MAGEB10 TKT MKI67 SMARCA4 KDM2B EP300 | 5.06e-07 | 593 | 151 | 18 | int:H2AX |
| Interaction | KIF23 interactions | ACADM ABHD12B PDHB ANXA2 ANXA2P2 FN3KRP COPG2 LARP4 DDB1 PRDX6 EEF1A1P5 CEP170 CLEC4E USP5 FRY DNAJC10 ALMS1 EIF4G1 MKI67 PLEC EIF4G3 TRIM37 DYNC1H1 AFF4 | 7.26e-07 | 1031 | 151 | 24 | int:KIF23 |
| Interaction | CEBPB interactions | ACADM PDHB CETN2 ANXA2 U2SURP ANXA11 GRB2 SRP54 QRICH1 GLOD4 PRDM7 DDB1 PRDX6 POLR3A EEF1A1 CEP170 ACSL1 NCOR2 USP5 RBM22 TKT EIF4G1 MKI67 SMARCA4 PLEC OGA FUBP3 EP300 DYNC1H1 | 9.09e-07 | 1443 | 151 | 29 | int:CEBPB |
| Interaction | CAPZB interactions | ABHD18 PDHB FN3KRP SRP54 QRICH1 DDB1 DARS2 EEF1A1 BICD1 SMTN CEP170 TAOK3 DNAJC10 AP2A2 EIF4G1 MKI67 PEAK1 OGA NEXN FUBP3 CNOT1 TRIM37 DYNC1H1 DNM2 | 9.87e-07 | 1049 | 151 | 24 | int:CAPZB |
| Interaction | DRG2 interactions | 1.36e-06 | 74 | 151 | 7 | int:DRG2 | |
| Interaction | KCTD13 interactions | TOM1L2 GPRASP1 ACSL6 DNAJC13 VWF KALRN PDHB ANXA2 ARFGEF2 GRB2 DDB1 CDC42BPB PRDX6 EEF1A1 CEP170 USP5 STXBP1 AP2A2 TKT PAFAH1B2 EIF4G1 SMARCA4 PEAK1 PLEC EIF4G3 CNOT1 DYNC1H1 DNM2 | 1.47e-06 | 1394 | 151 | 28 | int:KCTD13 |
| Interaction | BIRC3 interactions | ATP8B4 DNAH10 PDHB ANXA2 U2SURP FN3KRP DUOX2 GLOD4 PRDM7 DDB1 PRDX6 DARS2 EEF1A1 NCOR2 RBM22 IARS2 COMMD1 TM9SF2 TKT EIF4G1 MKI67 SMARCA4 PEAK1 FUBP3 CNOT1 EP300 DYNC1H1 | 2.02e-06 | 1334 | 151 | 27 | int:BIRC3 |
| Interaction | SIRT7 interactions | U2SURP ANXA11 COPG2 LARP4 DDB1 DICER1 CEP170 USP5 IARS2 PREP EIF4G1 MKI67 SMARCA4 PLEC EIF4G3 FUBP3 CNOT1 DYNC1H1 DNM2 | 3.12e-06 | 744 | 151 | 19 | int:SIRT7 |
| Interaction | SNW1 interactions | DNAJC13 U2SURP ARFGEF2 SRP54 COPG2 DDB1 EEF1A1 NCOR2 PPP2R1B RBM22 XPO6 MKI67 LRP2 PLEC TNNT1 CNOT1 TRIM37 EP300 DNM2 | 3.31e-06 | 747 | 151 | 19 | int:SNW1 |
| Interaction | CTTN interactions | GBF1 GRB2 EEF1A1 BICD1 STXBP1 PREP SMARCA4 LRPAP1 PEAK1 PLEC NEXN CNOT1 EP300 DNM2 | 7.64e-06 | 450 | 151 | 14 | int:CTTN |
| Interaction | USP53 interactions | 9.62e-06 | 138 | 151 | 8 | int:USP53 | |
| Interaction | FER1L6 interactions | 1.41e-05 | 7 | 151 | 3 | int:FER1L6 | |
| Interaction | RICTOR interactions | PDHB ANXA2 ARFGEF2 ARFGEF1 SRP54 DDB1 PRDX6 POLR3A EEF1A1 IARS2 DNAJC10 AP2A2 EIF4G1 PLEC OGA UAP1L1 EP300 DYNC1H1 | 1.58e-05 | 759 | 151 | 18 | int:RICTOR |
| Interaction | SHC1 interactions | GBF1 ANXA2 ARHGEF5 VPS33A GRB2 DDB1 EEF1A1P5 CEP170 STXBP1 AP2A2 PEAK1 DNM2 | 1.88e-05 | 362 | 151 | 12 | int:SHC1 |
| Interaction | ACTA1 interactions | GBF1 ANXA2 CYTH1 GRB2 USP5 XPO6 SMARCA4 PLEC NEXN TRIM37 EP300 DNM2 | 2.40e-05 | 371 | 151 | 12 | int:ACTA1 |
| Interaction | HTT interactions | ACSL6 ANK1 PDHB CETN2 GRB2 GRIK5 CPT1B DDB1 PRDX6 EEF1A1 ACSL1 USP5 STXBP1 COMMD1 AP2A2 TKT PLEC ATP1A4 DYNC1H1 DNM2 | 2.84e-05 | 949 | 151 | 20 | int:HTT |
| Interaction | DCPS interactions | DNAJC13 PDHB ACOX1 U2SURP SRM DDB1 RBM22 TAOK3 MKI67 LRPAP1 PLEC DYNC1H1 | 4.30e-05 | 394 | 151 | 12 | int:DCPS |
| Interaction | FXR1 interactions | GPRASP1 TUT4 VWF FOXQ1 LARP4 BICD1 CEP170 NCOR2 AP2A2 EIF4G1 SMARCA4 FUBP3 CNOT1 TRIM37 EP300 DNM2 | 5.20e-05 | 679 | 151 | 16 | int:FXR1 |
| Interaction | CRKL interactions | 5.51e-05 | 227 | 151 | 9 | int:CRKL | |
| Interaction | BRCA1 interactions | MAGEB2 GBF1 CETN1 MATK FN3KRP ARFGEF2 ARFGEF1 DDB1 SMTN CEP170 COMMD1 DNAJC10 ALMS1 PREP DBF4 TKT EIF4G1 MKI67 SMARCA4 PLEC CNOT1 EP300 DYNC1H1 | 5.64e-05 | 1249 | 151 | 23 | int:BRCA1 |
| Interaction | OBP2A interactions | 6.51e-05 | 11 | 151 | 3 | int:OBP2A | |
| Interaction | AGR2 interactions | ANXA2 VPS33A SRM GRB2 COPG2 DDB1 PRDX6 EEF1A1 USP5 IARS2 AP2A2 TKT EIF4G1 ALDH1A1 PEAK1 PLEC CNOT1 DYNC1H1 DNM2 | 7.33e-05 | 934 | 151 | 19 | int:AGR2 |
| Interaction | POC5 interactions | 8.04e-05 | 95 | 151 | 6 | int:POC5 | |
| Interaction | THRB interactions | 8.18e-05 | 186 | 151 | 8 | int:THRB | |
| Interaction | HSPB1 interactions | ANK1 ACADM GRB2 GLOD4 PRDX6 EEF1A1 SEPHS1 IARS2 TKT EIF4G1 SMARCA4 EIF4G3 NEXN YME1L1 TRIM37 DYNC1H1 | 8.50e-05 | 708 | 151 | 16 | int:HSPB1 |
| Interaction | MECP2 interactions | DNAJC13 KALRN PDHB ANXA2 ARHGEF5 CYTH1 U2SURP SRP54 DDB1 EEF1A1 CEP170 RBM22 DNAJC10 EIF4G1 MKI67 SMARCA4 LRPAP1 CDK11B PLEC CNOT1 EP300 DYNC1H1 AFF4 | 8.88e-05 | 1287 | 151 | 23 | int:MECP2 |
| Interaction | CYLD interactions | MAGEB2 DNAJC13 ANK1 ANXA2 U2SURP VPS33A GRB2 DDB1 BICD1 EEF1A1P5 CEP170 ALMS1 TKT EIF4G1 PLEC ATP1A4 OGA DYNC1H1 | 9.03e-05 | 868 | 151 | 18 | int:CYLD |
| Interaction | ISG15 interactions | ANXA2 DDB1 PRDX6 USP5 TM9SF2 AP2A2 TKT EIF4G1 ALDH1A1 PLEC OGA FUBP3 DYNC1H1 | 9.12e-05 | 494 | 151 | 13 | int:ISG15 |
| Interaction | SEPHS2 interactions | 9.25e-05 | 32 | 151 | 4 | int:SEPHS2 | |
| Interaction | ATXN1 interactions | MAGEB2 PDHB U2SURP COPG2 QRICH1 LARP4 PRDX6 DOCK5 NCOR2 STXBP1 AP2A2 EIF4G1 SMARCA4 GMPR CDK11B EIF4G3 FUBP3 CNOT1 TRIM37 DYNC1H1 | 9.96e-05 | 1039 | 151 | 20 | int:ATXN1 |
| Interaction | FOXP3 interactions | COPG2 KRIT1 INTS10 EIF4G1 SMARCA4 CDK11B PLEC EIF4G3 FUBP3 EP300 DYNC1H1 DNM2 | 1.03e-04 | 432 | 151 | 12 | int:FOXP3 |
| Interaction | NUDCD1 interactions | 1.09e-04 | 63 | 151 | 5 | int:NUDCD1 | |
| Interaction | BAP1 interactions | TOM1L2 GBF1 PDHB CETN2 ANXA2 U2SURP COPG2 DDB1 PRDX6 EEF1A1 CEP170 USP5 SEPHS1 AP2A2 PREP TKT EIF4G1 PLEC EIF4G3 OGA CNOT1 DYNC1H1 DNM2 | 1.21e-04 | 1314 | 151 | 23 | int:BAP1 |
| Interaction | POU5F1 interactions | DNAJC13 TUT4 ZNF157 CETN2 ANXA2 DDB1 EEF1A1 NCOR2 SCML2 SMARCA4 KDM2B FUBP3 CNOT1 DYNC1H1 | 1.31e-04 | 584 | 151 | 14 | int:POU5F1 |
| Interaction | RECQL4 interactions | PDHB ANXA2 VPS33A GRB2 NME2P1 SRP54 LARP4 DDB1 DICER1 PRDX6 DARS2 POLR3A NECAP1 EEF1A1 PPP2R1B RBM22 DNAJC10 AP2A2 TKT EIF4G1 PLEC YME1L1 FUBP3 EP300 | 1.33e-04 | 1412 | 151 | 24 | int:RECQL4 |
| Interaction | NAA40 interactions | CETN2 U2SURP SRP54 COPG2 GLOD4 GPRIN1 DDB1 PRDX6 CEP170 IARS2 SCML2 ALMS1 TKT MKI67 SMARCA4 EIF4G3 OGA AFF4 DNM2 | 1.34e-04 | 978 | 151 | 19 | int:NAA40 |
| Interaction | PSKH2 interactions | 1.47e-04 | 67 | 151 | 5 | int:PSKH2 | |
| Interaction | FBXO32 interactions | ANXA2 U2SURP COPG2 EEF1A1 SMARCA4 CDK11B PLEC OGA FUBP3 CNOT1 DNM2 | 1.62e-04 | 386 | 151 | 11 | int:FBXO32 |
| Interaction | TEDC2 interactions | 1.66e-04 | 206 | 151 | 8 | int:TEDC2 | |
| Interaction | OBP2B interactions | 1.66e-04 | 3 | 151 | 2 | int:OBP2B | |
| Interaction | FGD5 interactions | 1.71e-04 | 207 | 151 | 8 | int:FGD5 | |
| Interaction | PBK interactions | 1.77e-04 | 156 | 151 | 7 | int:PBK | |
| Interaction | FBXW8 interactions | 1.84e-04 | 157 | 151 | 7 | int:FBXW8 | |
| Interaction | NR4A1 interactions | 2.02e-04 | 212 | 151 | 8 | int:NR4A1 | |
| Interaction | TES interactions | 2.07e-04 | 332 | 151 | 10 | int:TES | |
| Interaction | PTEN interactions | ANXA2 ANXA2P2 ANXA11 GRB2 GPRIN1 DDB1 PRDX6 SMTN CEP170 NCOR2 DNAJC10 TKT MKI67 SMARCA4 PLEC YME1L1 FUBP3 TRIM37 | 2.10e-04 | 929 | 151 | 18 | int:PTEN |
| Interaction | HULC interactions | 2.15e-04 | 161 | 151 | 7 | int:HULC | |
| Interaction | AFMID interactions | 2.15e-04 | 16 | 151 | 3 | int:AFMID | |
| Interaction | ACSL6 interactions | 2.15e-04 | 16 | 151 | 3 | int:ACSL6 | |
| Interaction | ACE2 interactions | TUT4 ANXA2 ANXA2P2 U2SURP SRM SRP54 LARP4 PRDX6 EEF1A1 EEF1A1P5 TM9SF2 AP2A2 TKT EIF4G1 MKI67 ALDH1A1 PLEC FUBP3 CNOT1 DYNC1H1 | 2.29e-04 | 1106 | 151 | 20 | int:ACE2 |
| Interaction | XPC interactions | 2.79e-04 | 168 | 151 | 7 | int:XPC | |
| Interaction | CSDE1 interactions | 2.98e-04 | 284 | 151 | 9 | int:CSDE1 | |
| Interaction | AAK1 interactions | 3.03e-04 | 121 | 151 | 6 | int:AAK1 | |
| Interaction | KIF20A interactions | ACADM ANXA2 ANXA2P2 FN3KRP DDB1 CDC42BPB EEF1A1P5 SMTN CEP170 DOCK5 DNAJC10 ALMS1 AP2A2 MKI67 SMARCA4 PLEC YME1L1 UAP1L1 TRIM37 | 3.37e-04 | 1052 | 151 | 19 | int:KIF20A |
| Interaction | PROSER3 interactions | 3.66e-04 | 19 | 151 | 3 | int:PROSER3 | |
| Interaction | LRRK2 interactions | MATK U2SURP GLOD4 LARP4 DDB1 EEF1A1 TAOK3 TKT PAFAH1B2 PLEC DYNC1H1 AFF4 | 3.68e-04 | 496 | 151 | 12 | int:LRRK2 |
| Cytoband | 12q24.31 | 7.10e-06 | 80 | 151 | 5 | 12q24.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 1.08e-04 | 325 | 151 | 7 | chr9q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 4.74e-04 | 415 | 151 | 7 | chr12q24 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | TUT4 ABHD18 CYTH1 POLG ANXA11 FN3KRP GRB2 NLRP1 QRICH1 DICER1 NECAP1 CACNA2D4 XPO6 SMARCA4 CDK11B FUBP3 EP300 | 1.47e-07 | 634 | 150 | 17 | M40866 |
| Coexpression | GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN | 8.59e-06 | 177 | 150 | 8 | M6703 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DNAJC13 TUT4 GBF1 CYTH1 U2SURP ARFGEF1 LARP4 DICER1 KRIT1 BICD1 CEP170 NCOR2 TAOK3 XPO6 DBF4 EIF4G3 TRIM37 | 8.68e-06 | 856 | 150 | 17 | M4500 |
| Coexpression | MOOTHA_FFA_OXYDATION | 1.00e-05 | 24 | 150 | 4 | M15531 | |
| Coexpression | GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_UP | 2.01e-05 | 199 | 150 | 8 | M7619 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN | 2.08e-05 | 200 | 150 | 8 | M3893 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | TUT4 ABHD18 CYTH1 POLG ANXA11 FN3KRP NLRP1 QRICH1 DICER1 NECAP1 CACNA2D4 XPO6 SMARCA4 CDK11B FUBP3 EP300 | 6.53e-05 | 905 | 150 | 16 | M40865 |
| Coexpression | BAKKER_FOXO3_TARGETS_DN | 7.17e-05 | 176 | 150 | 7 | M2295 | |
| Coexpression | KIM_ALL_DISORDERS_CALB1_CORR_UP | KALRN PDHB CETN2 TBC1D9 NECAP1 CEP170 STXBP1 TKT OGA YME1L1 TRIM37 DYNC1H1 | 7.69e-05 | 547 | 150 | 12 | M2110 |
| Coexpression | GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_DN | 8.51e-05 | 125 | 150 | 6 | M8930 | |
| Coexpression | BAKKER_FOXO3_TARGETS_DN | 1.08e-04 | 188 | 150 | 7 | MM904 | |
| Coexpression | ZAMORA_NOS2_TARGETS_DN | 1.10e-04 | 82 | 150 | 5 | M1638 | |
| Coexpression | GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP | 1.40e-04 | 196 | 150 | 7 | M5862 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | GPRASP1 ACSL6 SLC4A8 ANK1 KALRN DDC TBC1D9 NECAP1 FRY TAOK3 STXBP1 PLCB1 | 1.42e-04 | 584 | 150 | 12 | M39068 |
| Coexpression | GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP | 1.49e-04 | 198 | 150 | 7 | M5856 | |
| Coexpression | KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP | ACADM PDHB CETN2 DDB1 PRDX6 NECAP1 EEF1A1 STXBP1 TKT LRPAP1 OGA TRIM37 DYNC1H1 | 1.52e-04 | 680 | 150 | 13 | M2107 |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP | 1.54e-04 | 199 | 150 | 7 | M10018 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 1.59e-04 | 200 | 150 | 7 | M9463 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP | 1.59e-04 | 200 | 150 | 7 | M9831 | |
| Coexpression | GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP | 1.59e-04 | 200 | 150 | 7 | M7478 | |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP | 1.59e-04 | 200 | 150 | 7 | M8959 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN | 1.59e-04 | 200 | 150 | 7 | M7993 | |
| Coexpression | GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP | 1.59e-04 | 200 | 150 | 7 | M7831 | |
| Coexpression | ZAMORA_NOS2_TARGETS_DN | 1.62e-04 | 89 | 150 | 5 | MM690 | |
| Coexpression | FEVR_CTNNB1_TARGETS_UP | ABHD18 ANXA2 STK17B MATK CYTH1 ACOX1 CDC42BPB DOCK5 STXBP1 AP2A2 MTF1 ALDH1A1 OGA | 1.71e-04 | 688 | 150 | 13 | M2342 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | 1.90e-04 | 429 | 150 | 10 | M45694 | |
| ToppCell | droplet-Kidney-nan-21m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-07 | 176 | 150 | 8 | 0475db3f860de1e216cbdeb886f7a75b9f4fc801 | |
| ToppCell | PBMC-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 3.91e-07 | 199 | 150 | 8 | ebf03979ef56e978d72db475bb635b43b9cbe402 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 4.06e-07 | 200 | 150 | 8 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.75e-06 | 181 | 150 | 7 | ee207ea171e2ffc22a7f850be57bb118a87e0f81 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 195 | 150 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.97e-06 | 198 | 150 | 7 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 5.31e-06 | 200 | 150 | 7 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(2)_48hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 1.11e-05 | 148 | 150 | 6 | a061a745c09254e063411b7d835d5597a0007e29 | |
| ToppCell | Immune_cells-Neutrophils|Immune_cells / Lineage and Cell class | 2.27e-05 | 168 | 150 | 6 | 3539f802fe0143da1462df0618f78f9f15143f71 | |
| ToppCell | 3'_v3-blood-Mast|blood / Manually curated celltypes from each tissue | 2.59e-05 | 172 | 150 | 6 | e7a46bbeff749ca59b9f1357409ce1ad59dd22dd | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.68e-05 | 173 | 150 | 6 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-05 | 174 | 150 | 6 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-05 | 175 | 150 | 6 | 076ad81d6cbeea5512393d192af3ab5aa1f82975 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-05 | 175 | 150 | 6 | 445ccb9744a3a9ff37164c532afbe769d306b6c8 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_MEMP|lymph-node_spleen / Manually curated celltypes from each tissue | 2.95e-05 | 176 | 150 | 6 | 23a8ec42ebd42c539865a12d09773af90f3f8848 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 177 | 150 | 6 | 7f58286fc8797e9bdcf8ece0849f55680905955d | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 3.35e-05 | 180 | 150 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-05 | 182 | 150 | 6 | 942c18a27b22fb33a5200d5717cad972f3ef0576 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 184 | 150 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 3.79e-05 | 184 | 150 | 6 | ed266bd2d12f86e8786473e64fbcd58319cd4c2a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 184 | 150 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 184 | 150 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | HSPCs-Eo/Baso_prog.|World / Lineage and Cell class | 3.90e-05 | 185 | 150 | 6 | b40ea11f5e536438b400ca5fddfd4559789036bd | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-05 | 187 | 150 | 6 | 236e9857729670e87eed30fad58f49e1f56e4a85 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.14e-05 | 187 | 150 | 6 | a716b64ca03d9b61da765bf87f065ac9393303f1 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 4.27e-05 | 188 | 150 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-05 | 188 | 150 | 6 | e1f18c11e4848978ca7bbe9271917da14b3f0523 | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-05 | 188 | 150 | 6 | 283a7a22db144e8f942904d4a38cac30874f6d9e | |
| ToppCell | HSPCs-Ery_prog.|HSPCs / Lineage and Cell class | 4.40e-05 | 189 | 150 | 6 | 37d2c45debed1564a40a1085b8b310c50923b9e7 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.40e-05 | 189 | 150 | 6 | f01158bb15df3117fae1271bf8cf8c2501422671 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.53e-05 | 190 | 150 | 6 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-05 | 191 | 150 | 6 | 52e8d7dfaf1ebb6df8bf3a1f4546af59faa67657 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.66e-05 | 191 | 150 | 6 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-05 | 191 | 150 | 6 | e8d56e9f43943e9cc4dce83f2c234f19c2dd487d | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.94e-05 | 193 | 150 | 6 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | COVID-19-Myeloid-TRAM2|COVID-19 / Condition, Lineage and Cell class | 5.08e-05 | 194 | 150 | 6 | c5bdf2b58c10dcb09797ddaf46b2e6c80d10399f | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.08e-05 | 194 | 150 | 6 | ad3eb98f94a007c5988ede06238255f5b03bee6e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic-basophil|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.08e-05 | 194 | 150 | 6 | aca009b9f1f320c0a65ea16df6595d7ede0b1fda | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 5.08e-05 | 194 | 150 | 6 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.08e-05 | 194 | 150 | 6 | a281ebab117589fc922ead0a712cfe0a844c94ac | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.23e-05 | 195 | 150 | 6 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 195 | 150 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | (09)_Ionocytes-(4)_1wkpi|(09)_Ionocytes / shred by cell type and Timepoint | 5.34e-05 | 22 | 150 | 3 | b35fb230042a027b10ef3e7ef09bf13ea1cdc506 | |
| ToppCell | COVID-19_Severe|World / disease group, cell group and cell class | 5.38e-05 | 196 | 150 | 6 | 3bedf60f662b373ad9d0f07d4da9f11864af3a74 | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 5.38e-05 | 196 | 150 | 6 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.38e-05 | 196 | 150 | 6 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | (08)_PNEC|World / shred by cell type and Timepoint | 5.38e-05 | 196 | 150 | 6 | 2ee37155c03cd5009427a4bffe6c80ed2ac6939e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.53e-05 | 197 | 150 | 6 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.53e-05 | 197 | 150 | 6 | 7619924615a43011b4a86efbe6e7e5445f96722b | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.53e-05 | 197 | 150 | 6 | 32484fb5dde0a4525dd8028dde01ca5a4e51e4b6 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-05 | 197 | 150 | 6 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_2|COVID-19_Mild / Disease condition and Cell class | 5.53e-05 | 197 | 150 | 6 | e844f660010d114d65bd814f3d3fccd8e4a6b8da | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-05 | 197 | 150 | 6 | 1eb9ff8467118b943b5d443cb996168e1e1206b5 | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.69e-05 | 198 | 150 | 6 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | PBMC-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 5.69e-05 | 198 | 150 | 6 | fb873b7636bb1c7b119dd5b23d7a20f518e6c6da | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.69e-05 | 198 | 150 | 6 | a7eed9eeb728a8796e2780090cc244856efd8c65 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.69e-05 | 198 | 150 | 6 | de21168c9c05873938cc65e82cce40ffd8e55df1 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|Control_saline / Treatment groups by lineage, cell group, cell type | 5.85e-05 | 199 | 150 | 6 | 86d4e5dd3bcc6bafa48fd0211dad39a2456b53be | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.85e-05 | 199 | 150 | 6 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.85e-05 | 199 | 150 | 6 | b768496381362f9a2706e0892b5a7a0db82e09ce | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 6.02e-05 | 200 | 150 | 6 | 4e489ecf472857357d45e9f6c7a812aa48b72ebf | |
| ToppCell | Lung_Parenchyma-Control|Lung_Parenchyma / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.02e-05 | 200 | 150 | 6 | 2cb0fba2477d885b62850e473b4b637a5af531a9 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-MAIT|Int-URO / Disease, condition lineage and cell class | 6.02e-05 | 200 | 150 | 6 | 043c18e79a969e37bbff86443e553ac09fe33f84 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.02e-05 | 200 | 150 | 6 | 326cae37cacd94b423a6ac8873ea56c5abaf0a0b | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.02e-05 | 200 | 150 | 6 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal|5w / Sample Type, Dataset, Time_group, and Cell type. | 6.02e-05 | 200 | 150 | 6 | fc73565f973c70915e7415f30d7295a63e33d712 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-BMP_responsible_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 6.02e-05 | 200 | 150 | 6 | ce8a3a8367bafdfabc7c2f96b003aa99526a54e4 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 6.02e-05 | 200 | 150 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_only / Treatment groups by lineage, cell group, cell type | 1.05e-04 | 138 | 150 | 5 | 6ddd50e44a3914596b4cd61ae64a987119fe7979 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-04 | 142 | 150 | 5 | 819e983688d126d89a71abc03d72525cc759a347 | |
| ToppCell | droplet-Liver-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 146 | 150 | 5 | d9df42f8e44018b149a84f07c540cdba74d6374a | |
| ToppCell | droplet-Liver-hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 146 | 150 | 5 | a9fa64617c7fb7a66de77360c5642c1da91e465c | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 146 | 150 | 5 | e03658ead410d003e2b18fe94da086a38560b8e7 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 146 | 150 | 5 | 9d7122cc640500c7cd93230df06e331c31625bd5 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 147 | 150 | 5 | 00619115b9a1ec2b967c2992043b41974ece63c4 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-04 | 148 | 150 | 5 | 9205b26e0d042b342cc643cda0f4f3f8bb392d00 | |
| ToppCell | Lymphoid-Lymphoid-NK_cells|Lymphoid / shred on cell class and cell subclass (v4) | 1.45e-04 | 148 | 150 | 5 | d51a4b654a88d58dcdf29c2bc362c0cc1c40723a | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-04 | 151 | 150 | 5 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-04 | 151 | 150 | 5 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-macrophage-B|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.64e-04 | 152 | 150 | 5 | 5ce8920aedd39a4daf7082153b5e213707c14227 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 154 | 150 | 5 | 1e32969bee810adaf2d560f0824a16227df513d8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-04 | 155 | 150 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-04 | 155 | 150 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 157 | 150 | 5 | 9021900d9b1a71210c9c414a9d165eaf399eb607 | |
| ToppCell | facs-GAT-Fat-24m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 157 | 150 | 5 | c4a0b6c95d353691fd2846002ce4bc7c2b0edd1c | |
| ToppCell | facs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 157 | 150 | 5 | 9d4308312301cb922f156a7b6aededc9e1c62807 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 157 | 150 | 5 | c8c627ca181856cd31dba4cf073c2be659a49dc1 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 161 | 150 | 5 | b9a63fc9becc44d305fc7c221283bf59ec06b10f | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.15e-04 | 161 | 150 | 5 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.34e-04 | 164 | 150 | 5 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 164 | 150 | 5 | 54f8f11d2fa899005530c08e7a1ee728c7b0799c | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue | 2.34e-04 | 164 | 150 | 5 | 3b6a32ba53d05f6818fe950ac426f489383b645a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.41e-04 | 165 | 150 | 5 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-mucus_secreting_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 165 | 150 | 5 | 7e7643834ed483aec04f513cca38d6367fda9ff8 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.41e-04 | 165 | 150 | 5 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | 390C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.47e-04 | 166 | 150 | 5 | 4ba3711a02d3695b27f7cefd7c60e3be009f5bef | |
| ToppCell | 390C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.47e-04 | 166 | 150 | 5 | 35f6ae2664935dda0d883b32a050ced843204f2d | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.62e-04 | 168 | 150 | 5 | fa7c0303918cea04e3f4c4f3cb079be19004d214 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-Neutrophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.62e-04 | 168 | 150 | 5 | 04259f5a9b067cd1b5619e34591e4b2fccc18535 | |
| ToppCell | Control-Epithelial_alveolar-Mes-like-AT1_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-04 | 168 | 150 | 5 | 49180994311b3f4f9ec338b1d35d8edd7422e3c9 | |
| Computational | Genes in the cancer module 184. | 7.60e-06 | 29 | 104 | 5 | MODULE_184 | |
| Computational | Fatty acid metabolism. | 9.05e-06 | 30 | 104 | 5 | MODULE_221 | |
| Drug | Methazolamide [554-57-4]; Down 200; 17uM; HL60; HT_HG-U133A | 6.66e-06 | 196 | 151 | 9 | 2733_DN | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; PC3; HT_HG-U133A | 6.93e-06 | 197 | 151 | 9 | 4277_DN | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; PC3; HG-U133A | 7.52e-06 | 199 | 151 | 9 | 1890_DN | |
| Disease | obsolete_red blood cell distribution width | DNAJC13 ANK1 KALRN STK17B CYTH1 U2SURP DUOX2 SMOC1 EEF1A1 EEF1A1P5 CEP170 DOCK5 INTS10 TAOK3 KDM2B GMPR EIF4G3 EP300 DNM2 | 3.86e-05 | 1347 | 146 | 19 | EFO_0005192 |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 7.27e-05 | 3 | 146 | 2 | DOID:0080463 (implicated_via_orthology) | |
| Disease | colorectal cancer, inflammatory bowel disease | 1.08e-04 | 19 | 146 | 3 | EFO_0003767, MONDO_0005575 | |
| Disease | epilepsy (implicated_via_orthology) | 1.66e-04 | 163 | 146 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | response to sertraline, psychotic symptom measurement, response to olanzapine | 2.41e-04 | 5 | 146 | 2 | EFO_0006327, EFO_0009182, GO_0097333 | |
| Disease | odorant-binding protein 2b measurement | 2.41e-04 | 5 | 146 | 2 | EFO_0801859 | |
| Disease | Autosomal Dominant Parkinsonism | 3.55e-04 | 28 | 146 | 3 | C0752098 | |
| Disease | Autosomal Dominant Juvenile Parkinson Disease | 3.55e-04 | 28 | 146 | 3 | C0752097 | |
| Disease | Parkinsonism, Experimental | 3.55e-04 | 28 | 146 | 3 | C0752101 | |
| Disease | Autosomal Recessive Parkinsonism | 3.55e-04 | 28 | 146 | 3 | C0752100 | |
| Disease | Familial Juvenile Parkinsonism | 3.55e-04 | 28 | 146 | 3 | C0752104 | |
| Disease | Ramsay Hunt Paralysis Syndrome | 3.55e-04 | 28 | 146 | 3 | C0242423 | |
| Disease | PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE | 3.55e-04 | 28 | 146 | 3 | C1868675 | |
| Disease | Parkinsonism, Juvenile | 4.37e-04 | 30 | 146 | 3 | C0752105 | |
| Disease | Parkinsonian Disorders | 4.37e-04 | 30 | 146 | 3 | C0242422 | |
| Disease | Liver Cirrhosis, Experimental | VWF ANXA2 U2SURP SMOC1 DDC TBC1D9 ACSL1 NCOR2 FRY MKI67 PLSCR2 ALDH1A1 | 4.88e-04 | 774 | 146 | 12 | C0023893 |
| Disease | pack-years measurement, systolic blood pressure | 6.35e-04 | 34 | 146 | 3 | EFO_0006335, EFO_0006526 | |
| Disease | diffuse large B-cell lymphoma (is_marker_for) | 6.68e-04 | 8 | 146 | 2 | DOID:0050745 (is_marker_for) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 6.80e-04 | 80 | 146 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 6.92e-04 | 35 | 146 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | hemoglobin A1 measurement | 1.17e-03 | 520 | 146 | 9 | EFO_0007629 | |
| Disease | insulin sensitivity measurement, glucose homeostasis measurement | 1.27e-03 | 43 | 146 | 3 | EFO_0004471, EFO_0006896 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 1.30e-03 | 11 | 146 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Copper-Overload Cirrhosis | 1.30e-03 | 11 | 146 | 2 | C1876165 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 1.55e-03 | 12 | 146 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | Weight Gain | 1.68e-03 | 102 | 146 | 4 | C0043094 | |
| Disease | mean platelet volume | ATP8B4 VWF KALRN PDHB ACOX1 U2SURP CDC42BPB EEF1A1P5 DOCK5 ACSL1 FRY PLCB1 PLEC | 1.72e-03 | 1020 | 146 | 13 | EFO_0004584 |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 1.83e-03 | 13 | 146 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 2.13e-03 | 14 | 146 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Malformations of Cortical Development | 2.13e-03 | 14 | 146 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 2.13e-03 | 14 | 146 | 2 | C0431380 | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 2.13e-03 | 14 | 146 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 2.13e-03 | 14 | 146 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | response to cisplatin, platinum measurement | 2.32e-03 | 53 | 146 | 3 | EFO_0010154, GO_0072718 | |
| Disease | peripheral arterial disease | 2.45e-03 | 54 | 146 | 3 | EFO_0004265 | |
| Disease | Small cell carcinoma of lung | 2.45e-03 | 54 | 146 | 3 | C0149925 | |
| Disease | Proteinuria | 2.45e-03 | 15 | 146 | 2 | HP_0000093 | |
| Disease | focal segmental glomerulosclerosis | 2.79e-03 | 16 | 146 | 2 | EFO_0004236 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 2.79e-03 | 16 | 146 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | response to radiation, Urinary retention | 3.15e-03 | 17 | 146 | 2 | GO_0009314, HP_0000016 | |
| Disease | Eye Abnormalities | 3.15e-03 | 17 | 146 | 2 | C0015393 | |
| Disease | cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant | 3.93e-03 | 19 | 146 | 2 | EFO_0007044, EFO_0020106 | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 3.93e-03 | 19 | 146 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | serum zinc measurement | 3.93e-03 | 19 | 146 | 2 | EFO_0005268 | |
| Disease | irritable bowel syndrome | 4.15e-03 | 131 | 146 | 4 | EFO_0000555 | |
| Disease | taurocholate measurement | 4.36e-03 | 20 | 146 | 2 | EFO_0010538 | |
| Disease | Schizophrenia | ACSL6 CETN1 GRB2 GRIK5 DICER1 PRDX6 STXBP1 LRP2 PLCB1 KDM2B ALDH1A1 | 4.57e-03 | 883 | 146 | 11 | C0036341 |
| Disease | response to bronchodilator, FEV/FEC ratio | KALRN ARHGEF5 GRIK5 TSEN2 DOCK5 NCOR2 RPRM PAFAH1B2 DNAAF1 TRIM37 | 4.92e-03 | 766 | 146 | 10 | EFO_0004713, GO_0097366 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ADRFSELQKAMGPKI | 276 | P30154 | |
| GEMRVPEEALKHEKF | 101 | Q5SW79 | |
| KTVEVKPGMKARFVD | 1331 | Q09472 | |
| DPLRDAEVLRKAMKG | 201 | P50995 | |
| ARELAPMIDKDKEAL | 656 | Q96G01 | |
| MKFAKERQPDEAVGK | 826 | Q5JQC9 | |
| EDMVRLGKDSGLKPF | 636 | P33121 | |
| PGEAQKIDRLMEKFA | 791 | Q9Y6D6 | |
| DTVVFREKKPKEVMG | 1066 | Q12774 | |
| KFVIFAKMNDPREGR | 1241 | P16157 | |
| PEDLKRLFEFRKMIG | 26 | Q0P651 | |
| PGFLRTLMDALRKDK | 266 | Q7Z5M8 | |
| PGEAQKIDRLMEKFA | 736 | Q9Y6D5 | |
| NFIPDEFKISKGLRM | 2656 | Q8TCU4 | |
| KKFGPEESRLVAEML | 971 | Q8IYW2 | |
| LLEAGKPFIKEASMA | 356 | P45954 | |
| TDEMRIAKEEIFGPV | 391 | P00352 | |
| SPYDMLESIRKEVKG | 236 | P07355 | |
| SIKMGDPKVHEFLRL | 456 | Q8TF62 | |
| MEKEKEGFPITSLRE | 471 | P21127 | |
| KVAMGAFDKTRPVVA | 271 | P11310 | |
| PKRESGEEFRMEKLN | 46 | P30533 | |
| EKMVAELTRKIGFDP | 301 | Q8N865 | |
| FMEDIEKSEARIGIP | 896 | Q9UPY3 | |
| DIEVPKAMGDIFESL | 1801 | Q9UPY3 | |
| AMRALGFEPKKEEIK | 56 | P41208 | |
| LERDKAAGLIPFFMV | 226 | P20711 | |
| SPYDMLESIRKEVKG | 236 | A6NMY6 | |
| RTGRLKKPFVKVEDM | 211 | Q9UBU7 | |
| EMKDFIGDRSIPKLV | 61 | Q9UHB7 | |
| REMAEAFAGEIPKVL | 141 | O94973 | |
| VRDAGLSFKDDMPKS | 96 | Q9NW64 | |
| GPSEKNARIFLMDKD | 291 | Q6ZTQ3 | |
| RMKEFLDSLASKGPE | 26 | Q2TAL8 | |
| GITKGVKEDFRLAME | 666 | Q9NVR2 | |
| RPGKLKLSFEEMERQ | 306 | Q0ZGT2 | |
| GKSEMEFIESKRPRL | 96 | Q9Y618 | |
| KYGDKRIIDTPISEM | 76 | P11177 | |
| KEVSEAVEKGYRMEP | 431 | P42679 | |
| EMLKIVGKRFREHFP | 136 | O15479 | |
| IEHFMFGEPRKLLTK | 236 | Q96LZ2 | |
| KVNPKAEARRMFEGE | 41 | Q9HA64 | |
| FRELSKMDPEGSKLL | 276 | Q9HC38 | |
| GDLKVPRMEEKEALV | 136 | Q9UK85 | |
| DILVVFMKGSPEDKS | 846 | Q9NRD8 | |
| DKEILRMAGPLTADF | 261 | Q8N6G6 | |
| GIQFPRDLDVKMKAV | 266 | Q9NRY7 | |
| TPKVMAGFLRGDKVI | 76 | Q96R09 | |
| EAKGESSEKPAIVFM | 976 | Q9H792 | |
| HFKEEGMLLEKPARV | 1186 | Q9C000 | |
| EFKVPDKMVGFIIGR | 81 | Q96I24 | |
| DAGKLFMVDSIPKVV | 696 | Q5H8C1 | |
| VVEGFMKRIEEKGVP | 1951 | O60229 | |
| KDKPTVERFIAMNRG | 206 | Q15438 | |
| KEPRELFVKGTMKDI | 371 | P54098 | |
| IFVGKEGTRMKVEDV | 321 | P52848 | |
| KFPLDGEKMGREASL | 96 | O00522 | |
| PKLERAFMDGSNRKD | 536 | P98164 | |
| DLSGIAEMFKTPVKE | 751 | P46013 | |
| KMEEKFRADTGLKLP | 931 | Q9Y5S2 | |
| VKAMVVDKDFPEDRR | 31 | Q9NY56 | |
| PLDNLKIRDVEKGFM | 566 | P50570 | |
| FFGKIPRAKAEEMLS | 61 | P62993 | |
| ERTERKPMVKDAFKD | 16 | Q9NQV7 | |
| MKVDGAKELPDVLER | 156 | P48147 | |
| VKAMVVDKDFPEDRR | 31 | Q9NPH6 | |
| VKKMREFGIADPDEI | 71 | Q15067 | |
| LIFREKDGLGIKMPD | 106 | Q8NHM5 | |
| DMFEDARPGVKKVAL | 886 | Q2UY09 | |
| LMDRPLEEAVKIKGA | 801 | Q9H7D0 | |
| LEMDDPRAVGKKLGF | 281 | O00341 | |
| VPMDKGKRVLFLTND | 621 | Q7Z3S7 | |
| PKFLKSGDAAIVDMV | 391 | P68104 | |
| KDMTGKEDVYRGPAI | 111 | Q9UBF2 | |
| AELFAKMTADKLIGP | 1876 | O75165 | |
| TIGKDLDFEKAKPRM | 941 | Q04637 | |
| KIGAEVRKDPFSQVM | 291 | Q6ZN28 | |
| REEVKTFQGKPIMAR | 256 | Q71RC2 | |
| EEFRPFLAKMRGILK | 46 | Q8N668 | |
| PGDRETRQKMELFVK | 366 | Q8NEP3 | |
| PKFLKSGDAAIVDMV | 391 | Q5VTE0 | |
| ADRDGDKMAPSVEKK | 171 | Q14204 | |
| RENPRLDKKMIGEFV | 741 | Q92538 | |
| EDMITGERKPKIDLF | 591 | Q5TBA9 | |
| FAPEFELLARMIKGK | 706 | Q8IXB1 | |
| MPRIDADLKLDFKDV | 1 | P36959 | |
| REKVIDFSKPFMTLG | 506 | Q16478 | |
| ATKEDSRFLGKMDPA | 366 | Q7Z2K8 | |
| DKVFKRIMGETLKDP | 1511 | Q8IVF4 | |
| MPKVFDLDQVRKRLG | 4211 | Q8IVF4 | |
| IGKDLDFEKAKPRMD | 936 | O43432 | |
| IAVMELFRPKGESKD | 61 | Q16531 | |
| RKLDREEIKPVMALG | 286 | Q92523 | |
| ILSAMNLDKFEKGPR | 166 | Q5VVW2 | |
| MKLEVFVPRAAHGDK | 1 | Q9C009 | |
| DPDGVLAEALAMFRK | 221 | Q6PF18 | |
| KDKEPDVLFVGDSMV | 36 | P68402 | |
| IDFMPGSIDVIKKES | 341 | Q5JY77 | |
| FEATMIDRKIGDKPI | 486 | Q2WGJ9 | |
| HGPLKEFKIFRAEMI | 31 | Q8NCE0 | |
| DKPDTRFGMKIIDIS | 331 | Q6PI48 | |
| AVFSGLPAVEKRRKM | 841 | O94972 | |
| LSERKKPLDIDYMGE | 186 | P13805 | |
| MDPVIIASEGVEKFK | 166 | P61011 | |
| MKKRVGAIEEFTFLP | 256 | Q5TGY1 | |
| KMEGFPKDVVILGRS | 901 | O60502 | |
| TPDDKMLRFVDKNGL | 21 | Q14872 | |
| KGFRLVAMKFLPASE | 16 | O60361 | |
| DFKRKMPDLPGAVDE | 346 | Q16773 | |
| EKDEKGMPVTARVVF | 121 | P30041 | |
| ERTERKPMVKDAFKD | 16 | Q9NQW5 | |
| AMEGKDEPLEFKRVL | 911 | O14802 | |
| KAEDRGMLLKTFNEP | 1131 | P51532 | |
| ERDKVMPLIIQGFKD | 136 | P49903 | |
| PLGDIKIVDFGMSRK | 171 | O94768 | |
| MRKGVLKDPEIADLF | 1 | Q9H2K8 | |
| PREMTADVIELKGKF | 946 | Q9NSE4 | |
| KMLEIGGDKFPLESR | 1031 | Q2Y0W8 | |
| VMSEAEKRPFIDEAK | 91 | O00570 | |
| TDAEGEKIKDPMRAI | 376 | P61764 | |
| DAVAFFVLPSKGKMR | 266 | Q86WD7 | |
| VMKFQDELESGKRPK | 851 | O15042 | |
| RFLPGKDLTEKEMIQ | 741 | Q8IYE0 | |
| LMDPFEEALKERGQK | 226 | Q9UKU0 | |
| KELKVAMRALGFEPR | 51 | Q12798 | |
| AEMREKNPKVAEIPF | 476 | Q13733 | |
| KPKMREFFIGLSDQV | 131 | Q9ULY5 | |
| FIQKTAVEKAGPEMD | 1506 | A5YKK6 | |
| PEGKKMEFITSLLDA | 316 | Q9H4F8 | |
| EEREKVTPLMVKGFR | 186 | Q99611 | |
| VTPLMVKGFRDAAEE | 191 | Q99611 | |
| AKPEMIFKLERGEEL | 71 | P51786 | |
| LFDGEVNVKRPMKDE | 936 | P04275 | |
| GKPAELLKMFGIDRD | 596 | P29401 | |
| GMINFLVKDRRPSKE | 86 | Q9NS64 | |
| NDFKVGMKLEARDPR | 61 | Q9UQR0 | |
| VAIKVIDKMGGPEEF | 36 | Q96PN8 | |
| VKFHRLFGMPEEEKL | 146 | Q6ZT07 | |
| VILERKDKVAMAPDG | 211 | Q3KQV9 | |
| DEDVIQVSKKFLPGM | 126 | P19623 | |
| EAVRMGIVGPEFKDK | 4126 | Q15149 | |
| MFGLPVDTRRKAFKT | 701 | Q9NQ66 | |
| MKSPDEVLREGELEK | 1 | Q53GA4 | |
| EFSKDKILMGPERRS | 571 | Q96TA2 | |
| MGARLVAAKLEPKSF | 226 | Q99805 | |
| EKMFTLKGNRLPAAD | 61 | Q96AX1 | |
| KSVLGRNFKMDRDLP | 1081 | Q96QU8 | |
| FFGRRKDMIAEKLAP | 141 | Q96N95 | |
| RKGVEFPMADLDALS | 146 | Q6ZVM7 | |
| DKFLEERAKAAEMVP | 461 | Q6ZVM7 | |
| PKRMDDFQLKGIVEE | 551 | Q5TAX3 | |
| KKMGSIFDREDQASP | 716 | P53814 | |
| KEVQDGIAPRMFKAL | 406 | P45974 | |
| MKIRFPGKSDAESEL | 691 | Q6ZT98 | |
| EEEAKRIAEMGKPVL | 646 | P57103 | |
| QEMDARPKLDLGFKE | 141 | Q8NC96 |